Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Swiss Group for Clinical Cancer Research

🇨🇭Switzerland

Country: 🇨🇭Switzerland

Ownership: Private

Established: 1965-01-01

Employees: -

Market Cap: -

Website: http://www.sakk.ch/

Clinical Trials

Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer
Adenocarcinoma

Interventions: Drug: Eribulin mesilate

First Posted Date: 2015-03-31

Last Posted Date: 2021-09-29

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 78

Registration Number: NCT02404506

Locations: 🇨🇭
Kantonsspital Aarau, Aarau, Switzerland
🇨🇭
Kantonsspital Baden, Baden, Switzerland
🇨🇭
Universitaetsspital-Basel, Basel, Switzerland

and more 23 locations

VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer

Phase 1

Completed

Conditions: Bladder Cancer

Interventions: Drug: VPM1002BC

First Posted Date: 2015-02-25

Last Posted Date: 2023-04-13

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 39

Registration Number: NCT02371447

Locations: 🇩🇪
Universitätsklinikum Freiburg, Freiburg, Germany
🇩🇪
Universitätsklinikum der Ruhr-Universität Bochum, Herne, Germany
🇩🇪
Universitätsklinikum Jena, Jena, Germany

and more 13 locations

Combination of Ibrutinib and Bortezomib to Treat Patients With Mantle Cell Lymphoma

Phase 1

Terminated

Conditions: Mantle Cell Lymphoma

Interventions: Drug: Ibrutinib
Drug: bortezomib

First Posted Date: 2015-02-05

Last Posted Date: 2022-03-11

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 58

Registration Number: NCT02356458

Locations: 🇩🇪
Universitätsmedizin Mainz, Mainz, Germany
🇩🇪
Klinikum der Universität München, München, Germany
🇩🇪
Universitätsmedizin Rostock, Rostock, Germany

and more 16 locations

Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation

Phase 2

Completed

Conditions: Myeloproliferative Neoplasm
Primary Myelofibrosis
Essential Thrombocythemia
Polycythemia Vera

Interventions: Drug: Mirabegron

First Posted Date: 2014-12-08

Last Posted Date: 2019-05-15

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 39

Registration Number: NCT02311569

Locations: 🇨🇭
Kantonsspital Aarau, Aarau, Switzerland
🇨🇭
Universitaetsspital-Basel, Basel, Switzerland
🇨🇭
Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni, Bellinzona, Switzerland

and more 8 locations

Impact of a Surgical Sealing Patch on Lymphatic Drainage After ALND for Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Drug: TachoSil® patches

First Posted Date: 2014-12-08

Last Posted Date: 2019-05-15

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 142

Registration Number: NCT02311543

Locations: 🇨🇭
Kantonsspital Aarau, Aarau, Switzerland
🇨🇭
Kantonsspital Baden, Baden, Switzerland
🇨🇭
Universitätsspital Basel, Basel, Switzerland

and more 13 locations

Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma

Phase 2

Completed

Conditions: Myeloma

Interventions: Drug: Nelfinavir
Drug: bortezomib
Drug: Dexamethasone

First Posted Date: 2014-07-11

Last Posted Date: 2019-06-26

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 34

Registration Number: NCT02188537

Locations: 🇨🇭
Kantonsspital Aarau, Aarau, Switzerland
🇨🇭
Kantonsspital Baden, Baden, Switzerland
🇨🇭
Universitaetsspital-Basel, Basel, Switzerland

and more 9 locations

CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer
Metastatic Breast Adenocarcinoma

Interventions: Drug: CR1447

First Posted Date: 2014-02-20

Last Posted Date: 2023-06-27

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 29

Registration Number: NCT02067741

Locations: 🇨🇭
Kantonsspital Aarau, Aarau, Switzerland
🇨🇭
Kantonsspital Baden, Baden, Switzerland
🇨🇭
Universitätsspital Basel, Basel, Switzerland

and more 10 locations

Early Hippocampal Avoidance Prophylactic Cranial Irradiation in Patients With LD SCLC

Not Applicable

Completed

Conditions: Small-Cell Lung Cancer

First Posted Date: 2014-02-07

Last Posted Date: 2020-01-29

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 44

Registration Number: NCT02058056

Locations: 🇨🇭
Universitätsspital Basel, Basel, Switzerland
🇨🇭
Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland
🇨🇭
Inselspital Bern, Bern, Switzerland

and more 5 locations

Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents

Phase 3

Withdrawn

Conditions: Prostate Cancer

Interventions: Drug: Orteronel
Drug: Placebo

First Posted Date: 2014-02-03

Last Posted Date: 2018-07-30

Lead Sponsor: Swiss Group for Clinical Cancer Research

Registration Number: NCT02053311

Locations: 🇨🇭
Kantonsspital Baden, Baden, Switzerland
🇨🇭
Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland
🇨🇭
Kantonsspital Graubuenden, Chur, Switzerland

and more 4 locations

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

Phase 3

Active, not recruiting

Conditions: Metastatic Breast Cancer
Metastatic Prostate Cancer
Bone Metastases

Interventions: Drug: Denosumab (standard dosing)
Drug: Denosumab (reduced dosing)

First Posted Date: 2014-01-31

Last Posted Date: 2025-03-13

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 1380

Registration Number: NCT02051218

Locations: 🇦🇹
Landeskrankenhaus Feldkirch, Feldkirch, Austria
🇦🇹
Klinikum Wels-Grieskrichen GmbH, Wels, Austria
🇩🇪
Uniklinik Düsseldorf, Urologische Klinik, Düsseldorf, Germany

and more 46 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy